These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 28423653)

  • 21. Upgrading the Repertoire of miRNAs in Gastric Adenocarcinoma to Provide a New Resource for Biomarker Discovery.
    Pewarchuk ME; Barros-Filho MC; Minatel BC; Cohn DE; Guisier F; Sage AP; Marshall EA; Stewart GL; Rock LD; Garnis C; Lam WL
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide analysis to identify a novel microRNA signature that predicts survival in patients with stomach adenocarcinoma.
    Luo SS; Liao XW; Zhu XD
    J Cancer; 2019; 10(25):6298-6313. PubMed ID: 31772663
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification of a six microRNA signature as a novel potential prognostic biomarker in patients with head and neck squamous cell carcinoma.
    Shi H; Chen J; Li Y; Li G; Zhong R; Du D; Meng R; Kong W; Lu M
    Oncotarget; 2016 Apr; 7(16):21579-90. PubMed ID: 26933913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M; Kong X; Wang H; Huang G; Ye C; He Z
    Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer.
    Zhou H; Tang K; Xiao H; Zeng J; Guan W; Guo X; Xu H; Ye Z
    J Exp Clin Cancer Res; 2015 May; 34(1):53. PubMed ID: 25991007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients.
    Kleivi Sahlberg K; Bottai G; Naume B; Burwinkel B; Calin GA; Børresen-Dale AL; Santarpia L
    Clin Cancer Res; 2015 Mar; 21(5):1207-14. PubMed ID: 25547678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma.
    Shi Y; Chen Z; Gao J; Wu S; Gao H; Feng G
    Oncol Rep; 2018 Oct; 40(4):2014-2022. PubMed ID: 30106437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis.
    Xiong J; Xiong K; Bing Z
    Cancer Biomark; 2018 Feb; 21(3):535-546. PubMed ID: 29226853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor Epigenetic Signature and Survival in Resected Gastric Cancer Patients.
    Woo Y; Behrendt CE; Yang A; Hahn M; Goel A; Li H; Yuan YC; Fong Y
    J Am Coll Surg; 2021 Apr; 232(4):483-491.e1. PubMed ID: 33465468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
    Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
    Gene; 2019 May; 697():86-93. PubMed ID: 30779946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a five-microRNA signature as a prognostic biomarker for esophageal squamous cell carcinoma.
    Yu J; Zhu M; Lv M; Wu X; Zhang X; Zhang Y; Li J; Zhang Q
    Sci Rep; 2019 Dec; 9(1):19847. PubMed ID: 31882677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis.
    Zhang MY; Li SH; Huang GL; Lin GH; Shuang ZY; Lao XM; Xu L; Lin XJ; Wang HY; Li SP
    BMC Cancer; 2015 Feb; 15():64. PubMed ID: 25880914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic values of GPNMB identified by mining TCGA database and STAD microenvironment.
    Yao K; Wei L; Zhang J; Wang C; Wang C; Qin C; Li S
    Aging (Albany NY); 2020 Aug; 12(16):16238-16254. PubMed ID: 32833670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A six-microRNA signature to predict outcomes of patients with gastric cancer.
    Chen J; Hu B; Wang W; Qian XJ; Shan BJ; He YF
    FEBS Open Bio; 2019 Mar; 9(3):538-547. PubMed ID: 30868062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
    Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P
    DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A five-miRNA signature predicts survival in gastric cancer using bioinformatics analysis.
    Zhang Z; Dong Y; Hua J; Xue H; Hu J; Jiang T; Shi L; Du J
    Gene; 2019 May; 699():125-134. PubMed ID: 30849543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
    Gu J; Li Y; Fan L; Zhao Q; Tan B; Hua K; Wu G
    Oncotarget; 2017 Jul; 8(30):49201-49216. PubMed ID: 28484081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An eight-miRNA signature expression-based risk scoring system for prediction of survival in pancreatic adenocarcinoma.
    Dou D; Yang S; Lin Y; Zhang J
    Cancer Biomark; 2018; 23(1):79-93. PubMed ID: 29991127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying potential prognostic biomarkers in head and neck cancer based on the analysis of microRNA expression profiles in TCGA database.
    Wang X; Yin Z; Zhao Y; He M; Dong C; Zhong M
    Mol Med Rep; 2020 Mar; 21(3):1647-1657. PubMed ID: 32016476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of a hypoxia-related microRNA signature in patients with colorectal cancer.
    Yang Y; Qu A; Wu Q; Zhang X; Wang L; Li C; Dong Z; Du L; Wang C
    Aging (Albany NY); 2020 Jan; 12(1):35-52. PubMed ID: 31926112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.